Angeion (St. Paul, Minnesota) said Richard Jahnke, president and chief executive officer of Angeion and its Medical Graphics subsidiary, plans to retire at the end of the fiscal year on Oct. 31. Jahnke became CEO of Medical Graphics in August 1998 and CEO of Angeion in January 2000 after Angeion acquired Medical Graphics the previous month. The board of directors has selected Rodney Young to succeed Jahnke. Young was most recently president and CEO of LecTec. He will join the company as executive vice president in July and assume the posts of president and CEO on Nov. 1. Angeion develops non-invasive cardiorespiratory diagnostic systems.
Patrick Verguet has been named president of Edwards Lifesciences' (Irvine, California) Edwards Europe unit. Verguet most recently served as Edwards' vice president of sales and country management of heart valve, cardiac surgery systems, and critical care operations in Europe, and is replacing Andre-Michel Ballester, who left Edwards Lifesciences to pursue other opportunities. Verguet has served in several sales and management positions within the company since he joined Edwards more than 20 years ago.
Enpath Medical (Plymouth, Minnesota) said Vincent Owens, currently president of the company's Lead Technologies Division (formerly Biomec Cardiovascular), would leave the company, effective at the end of June, to become president and chief executive officer of Texcel (East Longmeadow, Massachusetts). With Owens' departure, James Mellor Sr., vice president of sales and marketing of Enpath Medical, will also serve as acting president of the Lead Technologies Division. Enpath makes percutaneous delivery systems, stimulation leads technologies, and other products for use in pacemaker, defibrillator, catheter and infusion port procedures. Texcel assists companies with the development and manufacture of implantable FDA Class III medical devices, including implantable pulse generators for neurostimulation and cardiac rhythm management applications, hearing restoration devices, and cardiac assist pumps
Richard Ganz has been named president and chief executive officer of OmniSonics Medical Technologies (Wilmington, Massachusetts). Ganz most recently was president of Baxter Healthcare's North American renal business and prior to that held executive posts with Abbott Laboratories. OmniSonics is the developer of the OmniWave technology platform that is the basis for the Resolution System, which is designed to resolve occlusions that occur in hemodialysis access grafts and as a result of coronary artery disease, deep vein thrombosis and peripheral artery disease.